GAITHERSBURG, Md., Nov. 2, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it will report its third quarter 2023 financial results and operational highlights at 8:30 a.m. Eastern Standard Time (EST) on Thursday, November 9, 2023. Details of the event and replay are as follows:
Conference call details: | |
Date: | November 9, 2023 |
Time: | 8:30 a.m. U.S. EST |
Dial-in number: | (877) 550-1858 (Domestic) or (848) 488-9160 (International) |
Passcode: | 1754341 |
Webcast: |
Replay details: | |
Date: | Available starting at 11:30 a.m. EST, November 9, 2023, until |
Dial-in number: | (800) 645-7964 (Domestic) or (757) 849-6722 (International) |
Passcode: | 5567# |
Webcast: | ir.novavax.com/events, until February 7, 2024 |
About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to help protect against serious infectious diseases. Novavax, a global company based in Gaithersburg, Md., U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax's patented Matrix-M adjuvant to enhance the immune response. Focused on the world's most urgent health challenges, Novavax is currently evaluating vaccines for COVID-19, influenza and COVID-19 and influenza combined. Please visit novavax.com and LinkedIn for more information.
Contacts:
Investors
Erika Schultz
240-268-2022
This email address is being protected from spambots. You need JavaScript enabled to view it.
Media
Ali Chartan
240-720-7804
This email address is being protected from spambots. You need JavaScript enabled to view it.
| Last Trade: | US$7.32 |
| Daily Change: | 0.10 1.39 |
| Daily Volume: | 8,952,462 |
| Market Cap: | US$1.170B |
November 11, 2024 October 16, 2024 October 09, 2024 September 13, 2024 | |
Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MORE
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
